Emergency Dept Opportunity The Avalon-H90 cardio device targets hospital emergency departments for acute chest pain triage; focusing on ED adoption where triage speed and diagnostic clarity are critical can drive initial sales once regulatory approvals and clinical validation are in place.

Regulatory Gateways Mesuron is pursuing FDA and other regulatory approvals for the US, Canada, and Europe; partnering with regulatory experts and distributors can accelerate market entry and shorten the path to revenue.

Partnership Opportunities As a small team with a novel SQUID-based sensor, Mesuron could scale through contract manufacturing, distribution alliances, and co development deals with established medtech players to expand manufacturing capacity and geographic reach.

Pilot and Validation Prioritize clinical pilots and real world validation to demonstrate cost savings, improved triage speed, and diagnostic accuracy to hospital buyers and procurement teams.

Market Demand Fit A growing focus on non invasive cardiac screening and ED workflow optimization provides a favorable market context; Mesuron can position as a nimble, cost effective, faster to market option relative to larger incumbents.